Summary

Disposable wound management products play a pivotal role in the healthcare landscape of Europe, representing a critical component of patient care and safety. These innovative and indispensable medical devices are designed to effectively manage wounds while minimising the risk of infection and complications. Europe, with its diverse healthcare systems and stringent quality standards, has witnessed a burgeoning demand for disposable wound management products, driven by factors such as the increasing prevalence of chronic conditions, a rapidly ageing population, and the growing emphasis on infection control. These products encompass a wide array of items, ranging from sterile wound dressings and adhesive bandages to wound closure devices and surgical tapes, all of which are tailored to meet the specific needs of patients and healthcare professionals. As healthcare facilities strive to enhance patient outcomes and reduce the burden of healthcare-associated infections, the utilisation of disposable wound management products has become increasingly indispensable, making it a thriving sector within the European medical device market. The culture surrounding disposable wound management products in Europe reflects a deep commitment to healthcare excellence and patient well-being. Europe's diverse cultural landscape is united by a shared dedication to ensuring the highest standards of care, which extends to the selection and utilization of medical products like wound management supplies. In many European countries, there is a strong culture of prioritising patient safety and infection control. This emphasis is especially pertinent when it comes to wound care, as preventing infections and complications is a paramount concern. Disposable wound management products are seen as essential tools in achieving these goals. The culture encourages healthcare professionals to opt for single-use, sterile products to minimise the risk of cross-contamination and ensure the best possible outcomes for patients.

According to the research report, "Europe Disposable Wound Management Market Overview, 2028," published by Bonafide Research, the market is anticipated to add more than USD 1.50 Billion from 2023 to 2028. As individuals age, they become more susceptible to chronic conditions and injuries that require wound care. This demographic trend significantly contributes to the demand for wound management products. The increasing prevalence of chronic diseases such as diabetes and obesity in Europe has led to a higher incidence of chronic wounds, which require ongoing wound management. These conditions necessitate the use of specialised wound care products. For instance, the International Diabetes Federation projects that diabetes prevalence (9.2%) and the number of people with diabetes (61 million) in the EUR Region will increase by more than 10% by 2045. The EUR Region has the highest number of children and adolescents with type 1 diabetes (295,000) as well as the highest incidence annually, with above 30,000 new cases per year. The EUR region also has the second-highest average cost per person with diabetes (USD 3,086). In 2021, 189.3 billion USD were spent on diabetes, representing 19.6% of the total spent worldwide. Since the older population is at high risk of getting chronic illnesses, it is expected to generate the need for surgeries, thereby increasing demand for wound management devices and instruments and driving the market’s growth. Surgical procedures, whether elective or due to medical conditions, often require wound management. Europe's healthcare system offers a wide range of surgical treatments, further contributing to the demand for wound management products. The integration of telemedicine and digital health technologies in Europe has expanded the reach of wound care services. Remote monitoring and consultation require the use of wound management products, further increasing their demand.

According to the report, countries covered in this report include Germany, the UK, France, Italy, Russia, and Spain. Germany is known for its high standards of healthcare. The country has a well-developed healthcare infrastructure with advanced medical facilities and a focus on patient safety. This emphasis on quality care drives the demand for effective wound management products to maintain patient well-being. Germany, as part of the European Union, adheres to strict regulatory standards for medical devices, ensuring that only safe and effective wound management products are available on the market. This regulatory environment instills trust in healthcare products among both healthcare professionals and patients. Chronic conditions like diabetes and obesity are prevalent in Germany, leading to a higher incidence of chronic wounds that require specialised care and wound management products. Germany, like many Western European countries, emphasises home healthcare to reduce hospitalisation costs and improve patient comfort. This leads to the need for wound care products that can be effectively used in home settings. Germany is a hub for medical tourism, attracting patients from other countries for specialised medical treatments, including wound care. This influx of international patients contributes to the demand for high-quality wound management products.

Based on the product types, there are advanced wound care products, surgical wound care products, and traditional wound care products. In Europe, advanced wound management products will have the highest market share in 2022. Europe places a strong emphasis on infection control and patient safety in healthcare settings. Advanced wound care products often incorporate features such as antimicrobial properties or barrier films to reduce the risk of infections, making them a preferred choice in clinical practice. Ongoing research and development efforts in Europe have led to innovations in wound care technology. Advanced wound care products include items like bioactive dressings, negative pressure wound therapy systems, and cellular and tissue-based products. These innovations offer better wound healing outcomes and drive market growth. Europe's healthcare system is increasingly patient-centric, with a focus on improving the quality of life for patients. Advanced wound care products, which are designed for enhanced patient comfort and reduced pain during dressing changes, align with this approach and are preferred by both healthcare providers and patients. The integration of telemedicine and digital health technologies in Europe has expanded the reach of wound care services. Remote monitoring and consultation often involve the use of advanced wound care products, further driving demand.

In terms of the wound types, they are segmented into Surgical and Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Burns and Other Wounds. Europe is witnessing an increase in the prevalence of diabetes, particularly type 2 diabetes. As diabetes rates continue to rise, so does the likelihood of diabetic complications, including DFUs. A larger diabetic population contributes to the expanding market for DFU management products. While diabetes prevalence is rising, so is the quality of diabetes care in Europe. This leads to increased life expectancy for diabetic patients, but it also means they are more likely to experience long-term complications such as DFUs, necessitating ongoing treatment. There have been significant advancements in the development of wound care products tailored for DFU management. Advanced dressings, negative pressure wound therapy (NPWT) systems, and bioengineered skin substitutes have improved the efficacy of DFU treatment, driving market growth. Increased awareness about the risks of DFUs and the importance of early intervention has led to more proactive screening and management of diabetes-related foot complications. Healthcare professionals and patients are better educated about the need for appropriate products and care. Europe boasts a well-established and accessible healthcare infrastructure, which ensures that DFU management products are readily available and accessible to patients across the region. Europe has stringent regulations governing medical devices, including those used for DFU management. This regulatory environment ensures that products meet high safety and efficacy standards, fostering confidence in healthcare providers and patients.

Based on the end user, it is segmented into hospitals and clinics, long-term patient care, home care settings, and other end users. Home care settings are a growing market as the end user of the wound management market. European healthcare systems prioritise patient-centred care, aiming to provide services that are tailored to individual patient needs and preferences. This cultural focus aligns with the use of wound management products in home care settings, as it allows patients to receive treatment in a familiar and less institutionalised environment. There is a strong cultural value placed on maintaining and improving the quality of life for patients, especially those with chronic conditions or complex wounds. Home care settings allow patients to have a better quality of life by receiving wound care without the disruption and stress associated with hospital stays. European culture places a premium on independence and autonomy, particularly among older adults. Home care settings promote these values by allowing individuals to maintain a level of control over their daily routines and environment. Using wound management products at home aligns with this cultural emphasis. Europe boasts a well-developed healthcare infrastructure that supports home-based care. Skilled healthcare professionals, including nurses and wound care specialists, are trained to provide comprehensive care in home settings, including the use of advanced wound management products. European healthcare systems prioritise patient and carer education. Patients and their families are often provided with training on wound care and the proper use of wound management products, fostering a sense of empowerment and confidence in managing their condition at home.

Companies Covered in this reports:

Smith & Nephew plc, B. Braun Melsungen AG, Johnson and Johnson (Ethicon), Baxter International Inc., 3M, Medtronic Inc, Becton, Dickinson and Company, Medline Industries, Med-Con (Thailand) Co., Ltd., Nipro Corporation, Zimmer Biomet, Cardinal Health Inc, Molnlycke Health Care AB, Convatec Group PLC, Urgo Medical, Coloplast Corporation, Advancis Medical, Essity AB, Integra LifeSciences, Organogenesis Inc.

Considered in this report:

• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Europe Disposable Wound Management market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Aspects covered in this report:

• Europe Disposable Wound Management market Outlook with its value and forecast along with its segments
• Country-wise Transformers market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product Type:

• Advanced Wound Care Product
• Surgical Wound Care Product
• Traditional Wound care Product

By Wound Type:

• Surgical& Traumatic Wounds
• Diabetic Foot ulcers
• Pressure ulcers
• Venous leg Ulcers
• Burns & other Wounds

By End User:

• Hospitals and Clinics
• Long-term Patient care
• Home Care Settings
• Other End Users

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drone industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents